Geoff Meacham
Stock Analyst at Citi
(4.66)
# 801
Out of 4,345 analysts
1150
Total ratings
56.7%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,500 | $1,082.92 | +38.51% | 96 | May 27, 2026 | |
| MRK Merck & Co. | Maintained: Hold | $125 | $120.24 | +3.96% | 59 | May 26, 2026 | |
| PFE Pfizer | Maintained: Hold | $27 | $26.21 | +3.01% | 70 | May 26, 2026 | |
| RPRX Royalty Pharma | Maintained: Buy | $66 | $53.97 | +22.29% | 25 | May 26, 2026 | |
| SNSE Sensei Biotherapeutics | Initiated Coverage: Buy | $55 | $16.91 | +225.25% | 1 | May 22, 2026 | |
| REGN Regeneron Pharmaceuticals | Downgraded: Hold | $900 → $700 | $627.74 | +11.51% | 57 | May 18, 2026 | |
| MANE Veradermics | Maintained: Buy | $120 → $135 | $100.13 | +34.82% | 5 | May 18, 2026 | |
| PTGX Protagonist Therapeutics | Maintained: Buy | $130 | $102.21 | +27.19% | 11 | May 10, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $165 | $133.69 | +23.42% | 76 | May 7, 2026 | |
| NVAX Novavax | Maintained: Sell | $7 | $11.09 | -36.88% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 | $70.66 | +6.14% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $50.64 | +14.53% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $14.07 | +42.15% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $190 → $200 | $196.97 | +1.54% | 70 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $64 → $66 | $57.52 | +14.74% | 69 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $345 | $336.06 | +2.66% | 43 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $230 | $215.40 | +6.78% | 63 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $81.74 | +46.81% | 17 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $60 | $51.84 | +15.74% | 17 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $125 | $77.75 | +60.77% | 13 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $130 | $93.00 | +39.78% | 15 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $575 → $585 | $437.22 | +33.80% | 63 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $41 | $47.61 | -13.88% | 57 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $15.52 | +222.16% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $36.54 | +50.54% | 4 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.54 | +57.48% | 10 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $170 | $231.29 | n/a | 33 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.88 | n/a | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $52.46 | n/a | 35 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $2.31 | n/a | 8 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $53.53 | n/a | 8 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $3.06 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $9 | $16.62 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $30.01 | n/a | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $51.02 | n/a | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.95 | n/a | 4 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $15 | $33.15 | n/a | 4 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $51.58 | n/a | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.31 | n/a | 4 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $14 | $9.10 | n/a | 4 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $14.45 | n/a | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $62.03 | n/a | 1 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $18 | $66.44 | n/a | 6 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $23.97 | n/a | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $2 | $7.73 | n/a | 3 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $150 | $570.75 | n/a | 15 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $16 | $3.57 | n/a | 2 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $77.15 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $24 | $1.25 | n/a | 6 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $44 | $1.31 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $4 | $11.07 | n/a | 5 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $62 | $1.20 | n/a | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $20 | $12.47 | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $6.69 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49 → $75 | $10.07 | n/a | 10 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $1.54 | n/a | 1 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $27.65 | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 → $35 | $3.13 | n/a | 3 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $2.99 | n/a | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $9.12 | n/a | 1 | Dec 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $25.33 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.20 | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $12.85 | n/a | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $47.76 | n/a | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €77.36 | $129.50 | n/a | 1 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 → $32 | $0.2179 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $82 | $97.34 | n/a | 15 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $13 | $3.71 | n/a | 9 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $18.50 | n/a | 3 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $2.21 | n/a | 2 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $103 → $110 | $155.83 | n/a | 11 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $3.82 | n/a | 1 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.45 | n/a | 6 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $105 | $295.63 | n/a | 8 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $20 → $8 | $24.79 | n/a | 2 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $16 | $13.19 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 → $90 | $28.62 | n/a | 5 | Dec 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.83 | n/a | 1 | Sep 17, 2012 |
Eli Lilly and Company
May 27, 2026
Maintained: Buy
Price Target: $1,500
Current: $1,082.92
Upside: +38.51%
Merck & Co.
May 26, 2026
Maintained: Hold
Price Target: $125
Current: $120.24
Upside: +3.96%
Pfizer
May 26, 2026
Maintained: Hold
Price Target: $27
Current: $26.21
Upside: +3.01%
Royalty Pharma
May 26, 2026
Maintained: Buy
Price Target: $66
Current: $53.97
Upside: +22.29%
Sensei Biotherapeutics
May 22, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $16.91
Upside: +225.25%
Regeneron Pharmaceuticals
May 18, 2026
Downgraded: Hold
Price Target: $900 → $700
Current: $627.74
Upside: +11.51%
Veradermics
May 18, 2026
Maintained: Buy
Price Target: $120 → $135
Current: $100.13
Upside: +34.82%
Protagonist Therapeutics
May 10, 2026
Maintained: Buy
Price Target: $130
Current: $102.21
Upside: +27.19%
Gilead Sciences
May 7, 2026
Maintained: Buy
Price Target: $165
Current: $133.69
Upside: +23.42%
Novavax
May 7, 2026
Maintained: Sell
Price Target: $7
Current: $11.09
Upside: -36.88%
May 7, 2026
Maintained: Hold
Price Target: $75
Current: $70.66
Upside: +6.14%
May 7, 2026
Maintained: Buy
Price Target: $58
Current: $50.64
Upside: +14.53%
May 7, 2026
Maintained: Buy
Price Target: $20
Current: $14.07
Upside: +42.15%
May 4, 2026
Rated: Hold
Price Target: $190 → $200
Current: $196.97
Upside: +1.54%
May 4, 2026
Rated: Hold
Price Target: $64 → $66
Current: $57.52
Upside: +14.74%
May 1, 2026
Maintained: Hold
Price Target: $345
Current: $336.06
Upside: +2.66%
May 1, 2026
Maintained: Hold
Price Target: $230
Current: $215.40
Upside: +6.78%
Apr 30, 2026
Maintained: Buy
Price Target: $120
Current: $81.74
Upside: +46.81%
Apr 29, 2026
Maintained: Buy
Price Target: $50 → $60
Current: $51.84
Upside: +15.74%
Mar 24, 2026
Maintained: Buy
Price Target: $95 → $125
Current: $77.75
Upside: +60.77%
Mar 11, 2026
Maintained: Buy
Price Target: $145 → $130
Current: $93.00
Upside: +39.78%
Mar 10, 2026
Maintained: Buy
Price Target: $575 → $585
Current: $437.22
Upside: +33.80%
Mar 3, 2026
Maintained: Hold
Price Target: $41
Current: $47.61
Upside: -13.88%
Jan 30, 2026
Maintained: Buy
Price Target: $50
Current: $15.52
Upside: +222.16%
Jan 30, 2026
Maintained: Buy
Price Target: $55
Current: $36.54
Upside: +50.54%
Jan 30, 2026
Maintained: Buy
Price Target: $4
Current: $2.54
Upside: +57.48%
Jun 10, 2024
Maintained: Hold
Price Target: $170
Current: $231.29
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $22
Current: $1.88
Upside: n/a
Jun 4, 2024
Maintained: Buy
Price Target: $130
Current: $52.46
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: $17
Current: $2.31
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: $100
Current: $53.53
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $10 → $14
Current: $3.06
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $14 → $9
Current: $16.62
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $36
Current: $30.01
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $101
Current: $51.02
Upside: n/a
Mar 15, 2024
Rated: Hold
Price Target: n/a
Current: $0.95
Upside: n/a
Dec 15, 2023
Downgraded: Hold
Price Target: $23 → $15
Current: $33.15
Upside: n/a
Oct 11, 2023
Maintained: Sell
Price Target: n/a
Current: $51.58
Upside: n/a
Sep 29, 2023
Rated: Hold
Price Target: n/a
Current: $2.31
Upside: n/a
Sep 8, 2023
Downgraded: Hold
Price Target: $23 → $14
Current: $9.10
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: $35 → $25
Current: $14.45
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $13
Current: $62.03
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $13 → $18
Current: $66.44
Upside: n/a
Feb 28, 2023
Reiterated: Hold
Price Target: $23
Current: $23.97
Upside: n/a
Feb 23, 2023
Downgraded: Sell
Price Target: $8 → $2
Current: $7.73
Upside: n/a
Feb 22, 2023
Reiterated: Sell
Price Target: $80 → $150
Current: $570.75
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: $15 → $16
Current: $3.57
Upside: n/a
Feb 17, 2023
Initiated Coverage: Hold
Price Target: $49
Current: $77.15
Upside: n/a
Feb 16, 2023
Reiterated: Sell
Price Target: $2 → $24
Current: $1.25
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $83 → $44
Current: $1.31
Upside: n/a
Jun 8, 2022
Downgraded: Hold
Price Target: $12 → $4
Current: $11.07
Upside: n/a
May 18, 2022
Reiterated: Buy
Price Target: $75 → $62
Current: $1.20
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $28 → $20
Current: $12.47
Upside: n/a
Jan 13, 2022
Reiterated: Buy
Price Target: $60
Current: $6.69
Upside: n/a
Oct 8, 2021
Maintained: Hold
Price Target: $49 → $75
Current: $10.07
Upside: n/a
Jun 8, 2021
Upgraded: Hold
Price Target: n/a
Current: $1.54
Upside: n/a
Mar 19, 2021
Maintained: Buy
Price Target: $35
Current: $27.65
Upside: n/a
Jan 15, 2021
Downgraded: Hold
Price Target: $55 → $35
Current: $3.13
Upside: n/a
Jan 5, 2021
Maintained: Buy
Price Target: $70
Current: $2.99
Upside: n/a
Dec 7, 2020
Reiterated: Buy
Price Target: $9
Current: $9.12
Upside: n/a
Nov 23, 2020
Initiated Coverage: Buy
Price Target: $21
Current: $25.33
Upside: n/a
Sep 8, 2020
Initiated Coverage: Buy
Price Target: $20
Current: $0.20
Upside: n/a
Jun 25, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $12.85
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: $20 → $19
Current: $47.76
Upside: n/a
Feb 20, 2020
Maintained: Hold
Price Target: €77.36
Current: $129.50
Upside: n/a
Dec 3, 2019
Initiated Coverage: Buy
Price Target: $27 → $32
Current: $0.2179
Upside: n/a
May 3, 2019
Downgraded: Hold
Price Target: $90 → $82
Current: $97.34
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: $13 → $13
Current: $3.71
Upside: n/a
Mar 29, 2019
Maintained: Hold
Price Target: $8
Current: $18.50
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $27
Current: $2.21
Upside: n/a
Mar 28, 2019
Maintained: Buy
Price Target: $103 → $110
Current: $155.83
Upside: n/a
Mar 11, 2019
Initiated Coverage: Buy
Price Target: $16
Current: $3.82
Upside: n/a
Feb 20, 2019
Maintained: Buy
Price Target: n/a
Current: $7.45
Upside: n/a
Sep 7, 2017
Rated: Buy
Price Target: $80 → $105
Current: $295.63
Upside: n/a
Sep 7, 2017
Rated: Sell
Price Target: $20 → $8
Current: $24.79
Upside: n/a
Oct 23, 2015
Downgraded: Sell
Price Target: $25 → $16
Current: $13.19
Upside: n/a
Dec 2, 2014
Downgraded: Hold
Price Target: $60 → $90
Current: $28.62
Upside: n/a
Sep 17, 2012
Downgraded: Hold
Price Target: n/a
Current: $12.83
Upside: n/a